移植"不可移植者":高度致敏与ABO不相容肾移植的新进展
该综述指出,随着肾脏分配系统实施、配对捐赠项目扩展及脱敏与免疫抑制进步,原先被视为"不可移植"的候选者前景显著改善。分配系统优先考虑计算群体反应性抗体98%、99%、100%候选者的相容匹配,并将非A1及非A1-B亚组肾脏扩大分配至B型血候选者。作者建议不应因血型或供者特异性抗体将任何患者标记为不可移植,应提供个体化咨询并在需要时早期转诊至专家中心。
要点
- 肾脏分配系统优先为计算群体反应性抗体98%、99%、100%的候选者安排相容匹配。
- 非A1及非A1-B亚组肾脏扩大分配至B型血候选者。
- 脱敏与免疫抑制进展增强了对供者特异性抗体和抗体介导排斥的管理能力。
核心结论
- 随着分配系统、配对捐赠和脱敏免疫抑制进展,不可移植候选者的移植前景显著改善。
- 不应因ABO血型或供者特异性抗体将任何患者标记为不可移植。
研究设计与样本
- 本文为Perspective综述,讨论ABO血型不相容、HLA抗原不相容、抗体介导排斥、配对捐赠及不相容移植进展。
主要发现
- 肾脏分配系统优先考虑计算群体反应性抗体98%、99%、100%候选者的相容匹配。
- 非A1及非A1-B亚组肾脏被扩大分配至B型血候选者。
- 配对捐赠项目增长及将不相容移植纳入配对捐赠实现了「更相容」的肾移植。
- 脱敏与免疫抑制进展增强了对供者特异性抗体和抗体介导排斥的管理能力。
关键数值与推荐
- 计算群体反应性抗体98%、99%、100%的候选者被优先安排相容匹配。
- 非A1及非A1-B亚组肾脏扩大分配至B型血候选者。
临床怎么用
- 不应因血型或供者特异性抗体将患者标记为不可移植。
- 应为候选者提供个体化且现实的等待时间咨询,必要时早期转诊专家中心。
- 对致敏候选者应采用文中推荐的方法进行评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With implementation of the Kidney Allocation System, the growth of kidney paired donation programs, and advances in desensitization and immunosuppression, the outlook for "untransplantable" kidney transplantation candidates has never been more promising. The Kidney Allocation System prioritized compatible matches for candidates with calculated panel-reactive antibody levels of 98%, 99%, or 100% and broadened allocation of non-A1 and non-A1-B subgroup kidneys to blood group type B candidates. Concurrently, the growth of kidney paired donation programs and use of incompatible transplantation as part of kidney paired donation to achieve "more compatible" kidney transplantation has improved options for candidates with an incompatible living donor. Finally, advances in desensitization and immunosuppression have strengthened the ability to manage donor-specific antibodies and antibody-mediated rejection. Although no patient should be labeled "untransplantable" due to blood group type or donor-specific antibody, all candidates should be provided with individualized and realistic counseling regarding their anticipated wait times for deceased donor or kidney paired donation matching, with early referral to expert centers when needed. In this Perspective, we consider blood group type ABO incompatibility, HLA antigen incompatibility, antibody-mediated rejection, kidney paired donation, and recent developments in incompatible transplantation in more depth and recommend an approach to the sensitized candidate.
引用
- Holscher CM, Jackson KR, Segev DL, et al. Transplanting the Untransplantable. Am J Kidney Dis. 2019. PMID: 31255336. doi:10.1053/j.ajkd.2019.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。